Dolby Laboratories annual stock-based compensation
2008
2009
2010
2011
2012
2013
2014
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
2025
Dolby Laboratories Stock-Based Compensation Growth & History (DLB)
Dolby Laboratories's stock-based compensation was $128.5M for fiscal 2025.
View full Dolby Laboratories company overviewDolby Laboratories annual stock-based compensation history
| Fiscal year | Period ended | Stock-based compensation | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-09-26 | $128.5M | $8.7M | +7.25% |
| 2024 | 2024-09-27 | $119.8M | $1.3M | +1.13% |
| 2023 | 2023-09-29 | $118.5M | $3.6M | +3.10% |
| 2022 | 2022-09-30 | $114.9M | $15.2M | +15.27% |
| 2021 | 2021-09-24 | $99.7M | $13.1M | +15.09% |
| 2020 | 2020-09-25 | $86.6M | $10.0M | +13.12% |
| 2019 | 2019-09-27 | $76.6M | $5.3M | +7.48% |
| 2018 | 2018-09-28 | $71.2M | $5.9M | +9.04% |
| 2017 | 2017-09-29 | $65.3M | −$1.6M | −2.45% |
| 2016 | 2016-09-30 | $67.0M | −$84,000 | −0.13% |
| 2015 | 2015-09-25 | $67.1M | $1.4M | +2.11% |
| 2014 | 2014-09-26 | $65.7M | $1.4M | +2.10% |
| 2013 | 2013-09-27 | $64.3M | $16.7M | +35.20% |
| 2012 | 2012-09-28 | $47.6M | $3.9M | +8.97% |
| 2011 | 2011-09-30 | $43.7M | $14.8M | +51.54% |
| 2010 | 2010-09-24 | $28.8M | $6.4M | +28.51% |
| 2009 | 2009-09-25 | $22.4M | $90,000 | +0.40% |
| 2008 | 2008-09-26 | $22.3M | — | — |
Dolby Laboratories quarterly stock-based compensation
Q1.10
Q2.10
Q3.10
Q4.10
Q1.11
Q2.11
Q3.11
Q4.11
Q1.12
Q2.12
Q3.12
Q4.12
Q1.13
Q2.13
Q3.13
Q1.14
Q2.14
Q3.14
Q4.14
Q1.15
Q2.15
Q3.15
Q1.16
Q2.16
Q3.16
Q1.17
Q2.17
Q3.17
Q1.18
Q2.18
Q3.18
Q1.19
Q2.19
Q3.19
Q1.20
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
Q3.26
| Fiscal quarter | Period ended | Stock-based compensation | Change | YoY change |
|---|---|---|---|---|
| Q3 2026 | 2026-06-26 | $31.0M | $236,000 | +0.77% |
| Q2 2026 | 2026-03-27 | $30.7M | $44,000 | +0.14% |
| Q1 2026 | 2025-12-26 | $37.2M | $1.1M | +3.16% |
| Q4 2025 | 2025-09-26 | $31.1M | $1.4M | +4.63% |
| Q3 2025 | 2025-06-27 | $30.7M | $1.4M | +4.74% |
| Q2 2025 | 2025-03-28 | $30.7M | $1.7M | +6.05% |
| Q1 2025 | 2024-12-27 | $36.1M | $4.2M | +13.09% |
| Q4 2024 | 2024-09-27 | $29.7M | — | — |
| Q3 2024 | 2024-06-28 | $29.3M | $113,000 | +0.39% |
| Q2 2024 | 2024-03-29 | $28.9M | −$912,000 | −3.06% |
| Q1 2024 | 2023-12-29 | $31.9M | $654,000 | +2.09% |
| Q3 2023 · Jun 30 | 2023-06-30 | $29.2M | $1.6M | +5.85% |
| Q2 2023 · Mar 31 | 2023-03-31 | $29.8M | $2.1M | +7.68% |
| Q1 2023 · Dec 30 | 2022-12-30 | $31.2M | −$1.4M | −4.34% |
| Q3 2022 · Jul 1 | 2022-07-01 | $27.6M | $2.8M | +11.16% |
| Q2 2022 · Apr 1 | 2022-04-01 | $27.7M | $3.3M | +13.46% |
| Q1 2022 · Dec 31 | 2021-12-31 | $32.7M | $6.3M | +24.11% |
| Q3 2021 · Jun 25 | 2021-06-25 | $24.8M | $3.6M | +16.68% |
| Q2 2021 | 2021-03-26 | $24.4M | $3.5M | +16.52% |
| Q1 2021 · Dec 25 | 2020-12-25 | $26.3M | $3.7M | +16.36% |
| Q3 2020 · Jun 26 | 2020-06-26 | $21.3M | $2.4M | +12.84% |
| Q2 2020 | 2020-03-27 | $21.0M | $1.7M | +8.92% |
| Q1 2020 · Dec 27 | 2019-12-27 | $22.6M | $1.1M | +5.27% |
| Q3 2019 · Jun 28 | 2019-06-28 | $18.9M | $1.8M | +10.30% |
| Q2 2019 · Mar 29 | 2019-03-29 | $19.2M | $1.5M | +8.73% |
| Q1 2019 · Dec 28 | 2018-12-28 | $21.5M | $2.8M | +14.98% |
| Q3 2018 · Jun 29 | 2018-06-29 | $17.1M | $1.4M | +8.63% |
| Q2 2018 · Mar 30 | 2018-03-30 | $17.7M | $1.7M | +10.69% |
| Q1 2018 · Dec 29 | 2017-12-29 | $18.7M | $1.5M | +8.53% |
| Q3 2017 · Jun 30 | 2017-06-30 | $15.7M | −$265,000 | −1.66% |
| Q2 2017 · Mar 31 | 2017-03-31 | $16.0M | −$103,000 | −0.64% |
| Q1 2017 · Dec 30 | 2016-12-30 | $17.2M | −$2.2M | −11.17% |
| Q3 2016 · Jul 1 | 2016-07-01 | $16.0M | −$306,000 | −1.88% |
| Q2 2016 · Apr 1 | 2016-04-01 | $16.1M | −$581,000 | −3.49% |
| Q1 2016 · Jan 1 | 2016-01-01 | $19.4M | $1.5M | +8.62% |
| Q3 2015 · Jun 26 | 2015-06-26 | $16.3M | $347,000 | +2.17% |
| Q2 2015 · Mar 27 | 2015-03-27 | $16.7M | −$1.1M | −6.12% |
| Q1 2015 · Dec 26 | 2014-12-26 | $17.8M | $2.8M | +18.52% |
| Q4 2014 | 2014-09-26 | $16.9M | — | — |
| Q3 2014 | 2014-06-27 | $16.0M | −$1.3M | −7.62% |
| Q2 2014 | 2014-03-28 | $17.8M | $2.8M | +18.79% |
| Q1 2014 | 2013-12-27 | $15.1M | −$2.6M | −14.97% |
| Q3 2013 · Jun 28 | 2013-06-28 | $17.3M | $6.5M | +60.91% |
| Q2 2013 | 2013-03-29 | $14.9M | $2.9M | +23.89% |
| Q1 2013 | 2012-12-28 | $17.7M | $6.3M | +54.77% |
| Q4 2012 | 2012-09-28 | $13.3M | $2.6M | +24.09% |
| Q3 2012 | 2012-06-29 | $10.7M | −$175,000 | −1.60% |
| Q2 2012 | 2012-03-30 | $12.1M | $1.3M | +12.32% |
| Q1 2012 | 2011-12-30 | $11.4M | $179,000 | +1.59% |
| Q4 2011 | 2011-09-30 | $10.7M | $2.4M | +29.29% |
| Q3 2011 | 2011-07-01 | $10.9M | $2.9M | +35.38% |
| Q2 2011 | 2011-04-01 | $10.7M | $3.6M | +51.03% |
| Q1 2011 | 2010-12-31 | $11.3M | $5.9M | +111.38% |
| Q4 2010 | 2010-09-24 | $8.3M | — | — |
| Q3 2010 | 2010-06-25 | $8.1M | — | — |
| Q2 2010 | 2010-03-26 | $7.1M | — | — |
| Q1 2010 | 2009-12-25 | $5.3M | — | — |
Dolby Laboratories stock-based compensation trends
Over the last five fiscal years, Dolby Laboratories's stock-based compensation increased from $86.6M to $128.5M, a change of $41.9M. The latest reported quarter, Q3 2026, shows $31.0M.
About the metric
What stock-based compensation means
Stock-based compensation is the expense associated with equity awards such as restricted stock and employee options. It is a non-cash expense when recognized, but it can dilute existing shareholders unless offset by share repurchases.
Calculation and source
SEC-reported stock-based compensation
TickerStat standardizes share-based compensation reported in company SEC filings. The history shows recognized compensation expense or its cash-flow-statement adjustment, not the grant-date value of new awards or a forecast of future dilution. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Dolby Laboratories source filings ↗